Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Free 60-second assessment A simpler way to start provider-led weight care
Manufactured by Danish company Novo Nordisk, its aim is to curb the supply issues of GLP-1 analogue drugs, authorised to improve glycaemic control in the treatment of adults with type 2 diabetes that cannot be sufficiently controlled with diet and exercise
A meta-analysis of over 80,000 patients reported 16: 16% reduction in kidney failure risk 18% reduction in worsening kidney function These benefits are thought to be largely driven by improvements in: Blood sugar control Blood pressure Body weight and inflammation Fertility and Reproductive Function GLP-1 therapies have also been linked to improvements in fertility outcomes, particularly in individuals with obesity or insulin resistance
Lab and/or medical tests (such as kidney function, fasting blood glucose, hemoglobin A1c) should be done while you are taking this medication
These are naturally occurring hormones in your body that help regulate hunger and blood sugar
